VAXART (VXRT)
(Delayed Data from OTC)
$0.38 USD
-0.01 (-3.51%)
Updated Sep 17, 2025 09:58 AM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VXRT 0.38 -0.01(-3.51%)
Will VXRT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VXRT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VXRT
VAXART, INC. (VXRT) Reports Q2 Loss, Beats Revenue Estimates
Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates
VXRT: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Beauty Health Company (SKIN) Surpasses Q2 Earnings and Revenue Estimates
Select Medical (SEM) Surpasses Q2 Earnings and Revenue Estimates
VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates
Other News for VXRT
Crossed Above 20 Day Moving Average appears for VXRT after 7.41% move
VXRT Fell Below 20 Day Moving Average on September 15
VXRT forms 20 Day Moving Average Support on September 12
VXRT forms 20 Day Moving Average Support on September 11
Is VXRT ready to move higher? Crossed Above 20 Day Moving Average shows up after gaining 2.62%